COVID-19 Policy

Current as of April 27, 2023

Our highest priority is the health and safety of all AGBT attendees and stakeholders. We will follow all CDC guidelines as of August 1, 2023.

For updates to our plan and information about our COVID-19 policies, please bookmark this page or follow us on TwitterFacebook, or LinkedIn.


AGBT recommends that all attendees be fully vaccinated and have also received the most updated bivalent boosters targeting Omicron subvariants


AGBT recommends the wearing of masks in crowded indoor settings.   Attendees should bring their own well-fitting face masks that securely cover the nose and mouth.


In consideration of your colleagues:

  • AGBT encourages attendees to test for COVID-19 three days before departure to our meeting and to pack multiple self-test kits in your luggage
  • Do not attend AGBT if you test positive. Do not attend AGBT if you have symptoms that could be consistent with a “cold” or any other respiratory infection
  • If you begin experiencing symptoms on-site, you are encouraged to isolate and prepare to leave the meeting
  • Those who have tested positive in the prior ten-day period should not attend the meeting until they meet the CDC guidelines for ending isolation

You will be notified in advance of any changes to health requirements if AGBT determines a change is necessary.